ℹ️
🇬🇧
Search
Search for publications relevant for "mitoxantrone"
mitoxantrone
Publication
Class
Person
Publication
Programmes
Export current view
publication
Effect of L-carnitine against acute mitoxantrone toxicity in mice
2008 |
First Faculty of Medicine
publication
Biochemical and Pharmacological Effects of Mitoxantrone and Acetyl-L-Carnitine in Mice with a Solid Form of Ehrlich Tumour
2011 |
Faculty of Medicine in Hradec Králové
publication
Effect of L-carnitine against acute mitoxantrone toxicity in mice
+1
2008 |
Faculty of Medicine in Hradec Králové
publication
Evaluation of the antineoplastic activity of mitoxantrone-L-carnitine combination therapy on an experimental solid form of Ehrlich tumour in mice
2006 |
First Faculty of Medicine
publication
Evaluation of the antineoplastic activity of mitoxantrone-L-carnitine combination therapy on an experimental solid form of Ehrlich tumour in mice
+1
2006 |
Faculty of Medicine in Hradec Králové
publication
Mitoxanthrone in the treatment of active Multiple sclerosis (MS)
2003 |
First Faculty of Medicine
publication
Mitoxanthrone in the treatment of active Multiple sclerosis (MS)
2003 |
Faculty of Physical Education and Sport
publication
The effect of ATM and ERK1/2 inhibition on mitoxantrone-induced cell death of leukaemic cells
2011 |
Faculty of Medicine in Hradec Králové
publication
Randomised phase II study of second-line olaratumab with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer
2019 |
First Faculty of Medicine
publication
Subcellular Localization of Proteins Responding to Mitoxantrone-Induced DNA Damage in Leukaemic Cells
2015 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine
publication
Mitoxantrone in Combination with a DNA-PK Inhibitor: Possible Therapy of Promyelocytic Leukaemia Resistant Forms
2011 |
Faculty of Medicine in Hradec Králové
publication
Mitoxantrone ability to induce premature senescence in human dental pulp stem cells and human dermal fibroblasts
2013 |
Faculty of Medicine in Hradec Králové
publication
Current options in the treatment of multiple sclerosis
2010 |
Second Faculty of Medicine
publication
Anthracycline antibiotics derivate mitoxantrone-Destructive sorption and photocatalytic degradation
2018 |
First Faculty of Medicine
publication
Mitoxantron and inhibition of [8-3H]adenosine incorporation
1996 |
First Faculty of Medicine
publication
Olomoucine II and purvalanol A inhibit ABCG2 transporter in vitro and in situ and synergistically potentiate cytostatic effect of mitoxantrone
2012 |
Faculty of Pharmacy in Hradec Králové
publication
Biochemical aspects of possible therapeutic synergism of mitoxantrone with some L-carnitine derivatives, deoxysaccharides and trypsin
Publication without faculty affiliation
publication
Efficacy and Safety of Autologous Dendritic Cell-Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer The VIABLE Phase 3 Randomized Clinical Trial
2022 |
Faculty of Medicine in Hradec Králové
publication
Second induction with high-dose cytarabine and mitoxantrone: different impact on pediatric AML patients with t(8;21) and with inv(16)
2011 |
Second Faculty of Medicine
publication
Cabazitaxel in the treatment of a patient with prostate cancer
2020 |
Publication without faculty affiliation
publication
Autologous haematopoietic stem cell transplantation for secondary progressive multiple sclerosis: an exploratory cost-effectiveness analysis
2010 |
Third Faculty of Medicine
publication
Chemotherapy for acute myeloid leukemias with cytosine arabinoside, daunorubicin, etoposide, and mitoxantrone may cause permanent oligoasthenozoospermia or amenorrhea in middle-aged patients
2005 |
First Faculty of Medicine
publication
Chemotherapy for acute myeloid leukemias with cytosine arabinoside, daunorubicin, etoposide, and mitoxantrone may cause permanent oligoasthenozoospermia or amenorrhea in middle-aged patients
2005 |
Faculty of Physical Education and Sport
publication
Cabazitaxel in the treatment of patients with metastatic castration-resistant prostate cancer
2014 |
First Faculty of Medicine
publication
Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial
2015 |
Second Faculty of Medicine
publication
Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis
2022 |
First Faculty of Medicine
publication
Chemoresistant myeloid sarcoma responding to salvage therapy with combined azacitidine and venetoclax
2022 |
First Faculty of Medicine
publication
Multiple sclerosis
2011 |
First Faculty of Medicine